Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-24 @ 4:27 PM
Study NCT ID:
NCT04435366
Status:
COMPLETED
Last Update Posted:
2025-10-21
First Post:
2020-05-12
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
Sponsor:
IVERIC bio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-22
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-12
First Submit QC Date:
None
Study First Post Date:
2020-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-11-01
Results First Submit QC Date:
None
Results First Post Date:
2023-12-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-12-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-16
Last Update Post Date:
2025-10-21
Last Update Post Date Type:
ESTIMATED